Director of Bioconjugation & ADC/ARC Innovation

Bristol Myers Squibb; Cambridge (MA); Hybride; USD 190 000 - 270 000; Plein temps

Résumé du poste

Bristol Myers Squibb is seeking a Senior Scientific Leader at the Director level to define the bioconjugation platform and guide a team of scientists through target selection to candidate nomination and transition to development.

The role focuses on antibody-drug conjugates and antibody-RNA conjugates, requiring deep expertise in cysteine/lysine conjugation, site-specific and enzymatic methods, and experience with diverse payloads.

Qualifications

• PhD in chemistry or biochemistry with 8+ years in industry or academia, including leadership.
• Deep expertise in bioconjugation chemistry—cysteine/lysine conjugation, site-specific and enzymatic methods, click chemistry.

Responsabilités

• Set bioconjugation platform strategy; oversee chemistry, linker-payload design, and conjugation technology.
• Manage external collaborations.

Connaissances

Bioconjugation chemistry

Antibody-drug conjugates

Leadership / team management

Cross-functional collaboration

Site-specific conjugation

Formation

PhD in Chemistry or Biochemistry

Outils

RP-HPLC

SEC

LC-MS

Description du poste

Bristol Myers Squibb is seeking a Senior Scientific Leader at the Director level to define the bioconjugation platform and guide a team of scientists through target selection to candidate nomination and transition to development.

The role focuses on antibody-drug conjugates and antibody-RNA conjugates, requiring deep expertise in cysteine/lysine conjugation, site-specific and enzymatic methods, and experience with diverse payloads.